Given its central role in orchestrating sterile inflammation, IL-1, or IL-1R-targeting therapeutics have been proven effective in hereditary fever syndromes, Still disease, juvenile arthritis, gout, and cardiovascular events in including patients with T2DM (7–12). The gene discussed is IL1A; the disease is type 2 diabetes mellitus.